Title: Review article: efficacy of infliximab in Crohn's disease - induction and maintenance of remission
Authors: Rutgeerts, Paul # ×
Issue Date: Sep-1999
Publisher: Blackwell Science
Series Title: Alimentary Pharmacology & Therapeutics vol:13 pages:9-15
Conference: Symposium on New Advances in Inflammatory Bowel Disease - A Focus in Infliximab location:Vienna, Austria date:6 Sept 1998
Abstract: The primary goals of treating patients with Crohn's disease are to induce a clinical remission, maintain the remission, and prevent associated complications. Various treatment regimens for patients with Crohn's disease induce a response and remission; however, most prove ineffective for maintenance of the clinical effect. A therapeutic agent that can induce and maintain remission, while promoting the restoration of intestinal mucosa, would prove to be most beneficial in such a patient population.
ISSN: 0269-2813
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Translational Research in GastroIntestinal Disorders
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science